These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 22758628)
1. Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy. Kohli S; Ahuja S; Rani V Curr Cardiol Rev; 2011 Nov; 7(4):262-71. PubMed ID: 22758628 [TBL] [Abstract][Full Text] [Related]
2. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Balakumar P; Jagadeesh G Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208 [TBL] [Abstract][Full Text] [Related]
3. Calcium-dependent gene regulation in myocyte hypertrophy and remodeling. Williams RS; Rosenberg P Cold Spring Harb Symp Quant Biol; 2002; 67():339-44. PubMed ID: 12858558 [No Abstract] [Full Text] [Related]
4. Molecular targets and regulators of cardiac hypertrophy. Rohini A; Agrawal N; Koyani CN; Singh R Pharmacol Res; 2010 Apr; 61(4):269-80. PubMed ID: 19969085 [TBL] [Abstract][Full Text] [Related]
5. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. Fiedler B; Wollert KC Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470 [TBL] [Abstract][Full Text] [Related]
6. The CRM1 nuclear export receptor controls pathological cardiac gene expression. Harrison BC; Roberts CR; Hood DB; Sweeney M; Gould JM; Bush EW; McKinsey TA Mol Cell Biol; 2004 Dec; 24(24):10636-49. PubMed ID: 15572669 [TBL] [Abstract][Full Text] [Related]
7. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling. Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769 [TBL] [Abstract][Full Text] [Related]
8. Novel molecular targets in the treatment of cardiac hypertrophy. Luedde M; Katus HA; Frey N Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):1-20. PubMed ID: 18221071 [TBL] [Abstract][Full Text] [Related]
9. [The pathophysiological mechanism of cardiac development and hypertrophy, and heart failure]. Hasegawa H; Komuro I Nihon Rinsho; 2003 May; 61(5):704-7. PubMed ID: 12754991 [No Abstract] [Full Text] [Related]
10. Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure. Tian C; Hu G; Gao L; Hackfort BT; Zucker IH J Mol Cell Cardiol; 2020 Jun; 143():120-131. PubMed ID: 32370947 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A. Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809 [TBL] [Abstract][Full Text] [Related]
12. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling. Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805 [TBL] [Abstract][Full Text] [Related]
13. Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy. Deng KQ; Zhao GN; Wang Z; Fang J; Jiang Z; Gong J; Yan FJ; Zhu XY; Zhang P; She ZG; Li H Circulation; 2018 Apr; 137(14):1486-1504. PubMed ID: 29229612 [TBL] [Abstract][Full Text] [Related]
14. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation. Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677 [TBL] [Abstract][Full Text] [Related]
15. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Buitrago M; Lorenz K; Maass AH; Oberdorf-Maass S; Keller U; Schmitteckert EM; Ivashchenko Y; Lohse MJ; Engelhardt S Nat Med; 2005 Aug; 11(8):837-44. PubMed ID: 16025126 [TBL] [Abstract][Full Text] [Related]